Table Of Contents:
1. Market Context & Strategic Relevance
1.1 Opening Context (Why the market matters)
1.1.1 Why This Market Is Gaining Strategic Attention
1.1.2 Business Decisions This Report Supports
1.2 Scope
1.3 Research & Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Diagnostic Method
2.3.2 Market Size By Testing Setting
2.3.3 Market Size By Sample Collection
2.3.4 Market Size By End User
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Reagent, Enzyme & Raw Material Suppliers
3.4.2 Diagnostic Test & Instrument Manufacturers
3.4.3 Distributors & Reference Laboratories
3.4.4 Hospitals, Clinics & End Users
3.5 Industry Life Cycle Assessment
4. Statistical Insights & Trends Reporting (2025)
4.1 Disease Burden & Epidemiology Metrics
4.1.1 Global BV Prevalence by Region & Age Group
4.1.2 Recurrence Rates & Repeat Infection Statistics
4.1.3 BV Prevalence Among Pregnant Women
4.1.4 BV-Associated Complication Rates
4.2 Testing Volume & Utilization Statistics
4.2.1 Annual BV Test Volumes by Diagnostic Method
4.2.2 Molecular vs. Traditional Testing Adoption
4.2.3 Point-of-Care Testing Penetration
4.2.4 Self-Collected Sample Usage Rates
4.3 Clinical Performance Benchmarks
4.3.1 Sensitivity & Specificity by Diagnostic Method
4.3.2 Turnaround Time Benchmarks
4.3.3 Mixed Infection Detection Rates
4.3.4 Appropriate Treatment Rates After Testing
4.4 Product & Platform Mix Statistics
4.4.1 Multiplex Vaginal Panel Adoption
4.4.2 CLIA-Waived Platform Installed Base
4.4.3 High-Throughput Laboratory System Usage
4.4.4 At-Home & Telehealth Testing Volumes
4.5 Pricing & Reimbursement Metrics
4.5.1 Average Test Price by Diagnostic Method
4.5.2 Reimbursement Rates by Region
4.5.3 Payer Coverage for Molecular Panels
4.5.4 Out-of-Pocket Testing Costs
4.6 Regulatory & Innovation Indicators
4.6.1 FDA, CE-IVDR & Regional Approvals
4.6.2 CLIA Waiver Activity
4.6.3 Patent Filings & Technology Development
4.6.4 Product Launches & Funding Activity
5. Bacterial Vaginosis Diagnostics Market Segmental Analysis & Forecast, By Diagnostic Method, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 Molecular Diagnostics
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022–2035
5.3 Immunoassays
5.4 Rapid Diagnostic Tests
5.5 Vaginal pH Tests
5.6 Gram Stain & Microscopy
5.7 Other Methods
6. Bacterial Vaginosis Diagnostics Market Segmental Analysis & Forecast, By Testing Setting, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 Laboratory-Based Testing
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 Point-of-Care Testing
7. Bacterial Vaginosis Diagnostics Market Segmental Analysis & Forecast, By Sample Collection, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Clinician-Collected
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Self-Collected
8. Bacterial Vaginosis Diagnostics Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 Hospitals
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022–2035
8.3 Clinics
8.4 Diagnostic Laboratories
8.5 Other End Users
9. Bacterial Vaginosis Diagnostics Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Diagnostic Method, 2022–2035
9.2.3 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Testing Setting, 2022–2035
9.2.4 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Sample Collection, 2022–2035
9.2.5 Bacterial Vaginosis Diagnostics Market Size & Forecast, By End User, 2022–2035
9.2.6 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Country, 2022–2035
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Diagnostic Method, 2022–2035
9.3.3 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Testing Setting, 2022–2035
9.3.4 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Sample Collection, 2022–2035
9.3.5 Bacterial Vaginosis Diagnostics Market Size & Forecast, By End User, 2022–2035
9.3.6 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Country, 2022–2035
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Diagnostic Method, 2022–2035
9.4.3 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Testing Setting, 2022–2035
9.4.4 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Sample Collection, 2022–2035
9.4.5 Bacterial Vaginosis Diagnostics Market Size & Forecast, By End User, 2022–2035
9.4.6 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Country, 2022–2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Diagnostic Method, 2022–2035
9.5.3 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Testing Setting, 2022–2035
9.5.4 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Sample Collection, 2022–2035
9.5.5 Bacterial Vaginosis Diagnostics Market Size & Forecast, By End User, 2022–2035
9.5.6 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Country, 2022–2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Diagnostic Method, 2022–2035
9.6.3 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Testing Setting, 2022–2035
9.6.4 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Sample Collection, 2022–2035
9.6.5 Bacterial Vaginosis Diagnostics Market Size & Forecast, By End User, 2022–2035
9.6.6 Bacterial Vaginosis Diagnostics Market Size & Forecast, By Country, 2022–2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 South Africa
9.6.6.5 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Year-Wise Strategies & Development, 2022–2026
10.3 Market Share Analysis, 2025
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Becton, Dickinson and Company (BD)
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 Geographical Presence
10.6.1.5 SWOT Analysis
10.6.2 Hologic, Inc.
10.6.3 QIAGEN N.V.
10.6.4 Sekisui Diagnostics
10.6.5 bioMérieux SA
10.6.6 QuidelOrtho Corporation
10.6.7 Thermo Fisher Scientific Inc.
10.6.8 Cepheid (Danaher Corporation)
10.6.9 F. Hoffmann-La Roche Ltd.
10.6.10 Abbott Laboratories
10.6.11 Siemens Healthineers AG
10.6.12 PHASE Scientific International Ltd.
10.6.13 Seegene Inc.
10.6.14 Labcorp Holdings Inc.
10.6.15 Quest Diagnostics Incorporated
10.6.16 Bio-Rad Laboratories, Inc.
10.6.17 Heranova Lifesciences
10.6.18 Evvy
10.6.19 Hardy Diagnostics
10.6.20 Savyon Diagnostics Ltd.
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Frequently Asked Questions
Key players include Becton, Dickinson and Company, Hologic, Inc., QIAGEN N.V., Sekisui Diagnostics, and bioMérieux SA, among others.
Key opportunities include CLIA-waived point-of-care molecular testing, self-collected and at-home testing, and affordable rapid tests for high-prevalence emerging markets.
The primary growth factor is the high global prevalence of bacterial vaginosis, combined with the shift from subjective traditional methods to accurate molecular testing.
By diagnostic method, the Molecular Diagnostics segment dominates the Bacterial Vaginosis Diagnostics Market with approximately 38.64% share in 2025.
North America dominates the Bacterial Vaginosis Diagnostics Market with approximately 42.37% share in 2025.